Tampa’s Morphogenesis Wants To Cure Cancer With an Affordable Shot
A group of scientists in Tampa is working to make treating cancer as easy as getting a shot. While most of today's cancer treatments tend to be toxic and expensive, UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a clinical-stage biotechnology company, is working to develop immunotherapies that are safe and affordable.
Morphogenesis Awarded SBIR Funding for Cervical Cancer Therapy
UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a clinical-stage biotechnology company, has obtained funding to develop a new therapeutic drug to treat cervical cancer.
Morphogenesis’ Skin Cancer Vaccine Gets FDA ‘Fast Track’
Tampa company Morphogenesis, a UF startup, has received a “fast track” designation for its skin cancer vaccination from the United States Food and Drug Administration.
Tampa Company Developing Cancer Vaccines Could Receive Grant To Research Cervical Cancer Vaccine
UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a Tampa-based company that has been researching and developing a vaccine for certain types of skin cancers, could be soon receiving a grant to begin research on a cervical cancer treatment for underprivileged women.
Skin Cancer Vaccine Developed by Tampa Company Enters Phase 1 of Clinical Trial
UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc. completed its first-in-human phase one trial in cutaneous melanoma at Moffitt Cancer Center within the past year and has now moved into studying patients in earlier stages of skin cancers.
When Entrepreneurship Meets Healthcare: Lessons in Playing the Long Game
One medtech immunotherapy company called Morphogenesis in Tampa, Florida, a UF startup and UF Innovate | Sid Martin Biotech alum, is currently working on one of the highest-stakes medical issues of all: treating cancer.
Pets, Perseverance, and Manufacturing Facility Bring Biotech Success
Patricia Lawman, co-founder and CEO of the biotech firm Morphogenesis, a UF startup and UF Innovate | Sid Martin Biotech graduate company, has always been amazed at how our bodies can defeat illnesses and usually do it better than drugs.
Morphogenesis CEO Patricia Lawman Recognized As Health Care Innovator 2020 on Tampa Bay Business Journal
The Tampa Bay Business Journal recognized Patricia Lawman, founder and chief executive officer of UF startup and UF Innovate | Sid Martin Biotech graduate... Read More
Patricia Lawman Develops Novel Cell and Gene Therapies to Fight Cancer
Patricia Lawman is on a mission to change the future of cancer care. After losing her parents to lung cancer and lymphoma,... Read More
Bioscience Firm Makes Progress on Another Kind of Vaccine
The word vaccine carries heavy weight these days, with its tantalizing possibilities to curb the destruction brought on by a certain C-word.... Read More
